Send Inquiry

Request To Call Back

Bavencio 200 mg/10ml

Name: Bavencio 200 mg/10ml
Brand: K. K. PHARMA SOLUTIONS

Get a Price/Quote

MOQ : 10 Units

Bavencio 200 mg/10ml Specification

Dosage Form
Injection

Brand Name
Bavencio

Life Span
Check expiry date on packaging (usually 24 months from manufacturing date)

Origin of Medicine
Germany

Pacakaging (Quantity Per Box)
1 vial per box

Packaging Type
Vial

Indication
Treatment of metastatic Merkel cell carcinoma, advanced urothelial carcinoma, and other cancers as per licensing

Salt Composition
Avelumab

Drug Type
Biological/Anticancer

Ingredients
Avelumab (200 mg/10 ml) and excipients

Physical Form
Injection (solution for infusion)

Function

Recommended For
Adults with metastatic Merkel cell carcinoma, urothelial carcinoma, renal cell carcinoma, and other approved indications

Dosage
200 mg administered intravenously over 60 minutes every 2 weeks

Dosage Guidelines
Administer under supervision of a qualified healthcare professional. Dosage may be adjusted based on tolerance and clinical response.

Suitable For
Adults

Quantity
10 ml vial

Storage Instructions
Store in a refrigerator at 2C-8C. Do not freeze. Protect from light.

Regulatory Approval
US FDA, EMA, and other local regulatory bodies

Dilution Required
Yes, dilute with 0.9% sodium chloride prior to infusion

Appearance
Clear to slightly opalescent, colorless to slightly yellow solution

Prescription Status
Prescription Only

ATC Code
L01XC31

Patient Monitoring
Regular assessment for immune-related adverse events required

Adverse Effects
Infusion-related reactions, immunological adverse effects, fatigue, musculoskeletal pain, diarrhea

Contraindications
Hypersensitivity to avelumab or any excipients

Route of Administration
Intravenous infusion

Concentration
20 mg/ml

Disposal Requirements
Dispose of unused product and waste material in compliance with local requirements

About Bavencio 200 mg/10ml

Procure the new, top-tier Bavencio 200 mg/10ml, an exceptional anticancer therapy featuring avelumab, renowned for its classic immunotherapeutic function. This spectacular, FDA and EMA-approved solution is ideal for adults with metastatic Merkel cell carcinoma, advanced urothelial carcinoma, renal cell carcinoma, and other licensed indications. Available at a discount from leading exporters and suppliers, this prescription-only medication is administered intravenously after dilution, ensuring patient safety and efficacy. Each vial (10 ml) contains 200 mg of avelumab in a clear, colorless to lightly yellow fluid, crafted for dependable clinical outcomes.

Specific Usage & Versatile Applications of Bavencio 200 mg/10ml

Bavencio 200 mg/10ml is specifically indicated for the treatment of metastatic Merkel cell carcinoma, advanced urothelial carcinoma, and renal cell carcinoma in adults. This solution must be diluted with 0.9% sodium chloride and administered intravenously under the supervision of a qualified healthcare professional. Regular patient monitoring is essential to manage potential immune-related adverse effects. Its classic monoclonal antibody mechanism offers spectacular benefits in various approved oncological therapy settings.

Certifications, Sample Policy & Express Shipping Options for Bavencio

Bavencio 200 mg/10ml boasts top certifications from US FDA, EMA, and other global authorities. Exporters and suppliers offer competitive sample policies and ensure express shipping via reliable FOB ports for international orders. Customers can take advantage of freight efficiencies and secure the lowest prices. Each vial is packed for quality and compliance, providing assurance in both regulatory standards and supply chain excellence.

FAQ's of Bavencio 200 mg/10ml:

Q: How should Bavencio 200 mg/10ml be administered for optimal effectiveness?

A: Bavencio should be diluted with 0.9% sodium chloride and then administered as an intravenous infusion over 60 minutes every two weeks, under the supervision of a qualified healthcare professional.

Q: What are the primary clinical indications for Bavencio 200 mg/10ml?

A: Bavencio is recommended for adults with metastatic Merkel cell carcinoma, advanced urothelial carcinoma, and renal cell carcinoma as per licensed indications.

Q: When is patient monitoring required during Bavencio therapy?

A: Patient monitoring is essential both before and throughout Bavencio therapy, especially for early identification and management of immune-related adverse events.

Q: Where should Bavencio 200 mg/10ml vials be stored?

A: Vials should be stored in a refrigerator at 2C to 8C, protected from light and never frozen, following the product's storage guidelines.

Q: What is the process for disposing of unused Bavencio or waste material?

A: Disposal of any unused Bavencio and related waste must be conducted in compliance with local pharmaceutical regulations to ensure environmental and community safety.

Q: How does Bavencio benefit patients as a top-tier immunotherapy solution?

A: Bavencio works as a classic anti-PD-L1 monoclonal antibody, engaging the immune system to target cancer cells effectively, and offers a well-documented safety and efficacy profile for approved oncology indications.

Tell us about your requirement